The clinical application of mNGS in patients with severe infection in ICU

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043089

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-02-05

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe infection?sepsis

Interventions

survivor/non-survivor:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Organ dysfunction was identified as an acute change in total sequential organ failure assessment(SOFA) score = 2 points consequent to the confirmed or suspected infection. 2. Patients who received mNGS during ICU stay.

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years old; 2. Diagnosed with brain death before ICU admission.

Design outcomes

Primary

Measure	Time frame
the all-cause mortality at 28 days;	—

Secondary

Measure	Time frame
risk factors of mortality;	—

Countries

China

Contacts

Public ContactHe Dehua

The Affiliated Hospital of Guizhou Medical University

1635543116@qq.com+86 18111842113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026